Nicole Yurgin is the Executive Director of US Medical Value and Access at Amgen Inc. In this role, Nicole leads a US medical team that communicates the clinical and economic value of Amgen’s biopharmaceutical innovations with payers and other formulary decision makers. Nicole is passionate about improving the lives of people at risk of with serious diseases by ensuring access to innovative therapies.
Nicole has extensive experience in creating real world evidence programs and developing FDAMA 114 materials. Nicole has held various roles in Global, US and European Health Economics and Access functions at Amgen Inc. and at Eli Lilly and Company. Prior to joining industry, Nicole was an Assistant Professor in the Department of Economics at University of Toledo. Nicole holds a Ph.D. in Economics from The Florida State University.